mgiuliani

Johnson & Johnson (JNJ)

看多
NYSE:JNJ   Johnson & Johnson
9
The acquisition of Actelion for 30 mld dollars is a good strike, the EPS for the 2017 are at 6.60 dollars (1.65 dollars for quarter), this equity has a good yield and bright dividend growth prospects. In our view we think that it is a buy stock, with an interesting dividend yeld of 2.85%

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。